Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Severe airway stenosis associated with Crohn's disease: Case report

  • Maria Plataki1,
  • Eleni Tzortzaki1,
  • Irene Lambiri1,
  • Elpida Giannikaki2,
  • Armin Ernst3 and
  • Nikolaos M Siafakas1Email author
Contributed equally
BMC Pulmonary Medicine20066:7

DOI: 10.1186/1471-2466-6-7

Received: 03 January 2006

Accepted: 07 April 2006

Published: 07 April 2006

Abstract

Background

Symptomatic respiratory tract involvement is not common in Crohn's disease. Upper-airway obstruction has been reported before in Crohn's disease and usually responds well to steroid treatment.

Case presentation

We report a case of a 32-year old patient with Crohn's disease who presented with progressively worsening dyspnea on exertion. Magnetic Resonance Imaging of the chest and bronchoscopy revealed severe tracheal stenosis and marked inflammation of tracheal mucosa. Histopathology of the lesion showed acute and chronic inflammation and extended ulceration of bronchial mucosa, without granulomas. Tracheal stenosis was attributed to Crohn's disease after exclusion of other possible causes and oral and inhaled steroids were administered. Despite steroid treatment, tracheal stenosis persisted and only mild symptomatic improvement was noted after 8 months of therapy. The patient subsequently underwent rigid bronchoscopy with successful dilatation and ablation of the stenosed areas and remission of her symptoms.

Conclusion

Respiratory involvement in Crohn's disease might be more common than appreciated. Interventional pulmonology techniques should be considered in cases of tracheal stenosis due to Crohn's disease refractory to steroid treatment.

Background

Crohn's disease (CD) is a nonspecific chronic inflammatory disease that most commonly affects the distal ileum and colon and occasionally exhibits extra-intestinal manifestations. Symptomatic respiratory tract involvement is not common, pulmonary lesions, however, have been reported in CD, including chronic bronchitis [1], bronchiectasis [1, 2], upper-airway obstruction [37], bronchiolitis obliterans organizing pneumonia [1], granulomatous lung disease [1, 8, 9] and interstitial lung disease [10]. This report describes a young patient with CD who developed severe tracheal stenosis.

Case presentation

A 32-yr old Caucasian female patient presented in September 2004 with progressively worsening dyspnea on exertion. Since 2002, she had suffered from typical CD with arthritis, which had been diagnosed on clinical, endoscopic and histological grounds. She had undergone colonoscopy and biopsy in order to investigate symptoms of persistent diarrhea with abdominal pain, weight loss and fever. Colonoscopy had revealed mucosal ulcerations involving the distal ileum and right colon alternating with areas of normal-appearing mucosa and histological examination had shown transmural inflammation and epithelioid granulomas, typical of CD. In the following years, her gastrointestinal symptoms were well-controlled on sulphasalazine 3000 mg·day-1, azathioprine 100 mg·day-1 and folic acid 5 mg·day-1 and she experienced no exacerbations. Over the past year she has suffered from recurrent episodes of acute bronchitis. She has been repeatedly treated with antibiotics and short courses of oral steroids, followed by improvement of symptoms of infection (cough and sputum production). She complained, however, of progressive deterioration of her dyspnea and was referred by her family doctor to the Thoracic Department of the University Hospital of Heraklion for further evaluation and treatment.

On presentation, severe dyspnea on exertion subsiding at rest was noted. On physical examination, the patient was tachypnoeic and had stridor, reduced breath sounds and diffuse wheezing on auscultation. She was a lifelong non-smoker and had no history of occupational or environmental exposure relevant to lung disease. Her temperature was 36.6°C and her arterial oxygen saturation at rest was 97% (room air). Post exertion arterial blood-gas analysis did not reveal hypoxemia (alveolar-arterial oxygen tension gradient at peak exercise was 10 mmHg). The electrocardiogram and chest radiographs were normal. Laboratory investigations showed normal serum values of electrolytes, glucose, protein, liver function tests, urea and creatinine. Other laboratory tests showed a moderately increased erythrocyte sedimentation rate of 31 mm·1 h-1, and normal C-reactive protein (< 0.32 mg/dl). Complete blood count revealed mildly elevated white blood cell count (12.3 K·μl-1, 90.8% neutrophils). Assessments of anti-nuclear antibodies, anti-DNA antibodies, anti-neutrophil cytoplasmic antibodies (ANCA, both cytoplasmic- and perinuclear-ANCA), and serum angiotensin-converting enzyme (sACE) were normal. Serologic tests for Mycoplasma pneumoniae, Chlamydia pneumoniae, respiratory syncytial virus, adenovirus, and influenza viruses were all negative. Tuberculin skin test was negative. Sputum cultures for mycobacteria and fungi were negative. Pulmonary function tests showed airway obstruction (Table 1) and flow-volume curve intra-extrathoracic airway obstruction. There was no improvement in forced expiratory volume in one second (FEV1) following inhalation of β2-agonist. Magnetic resonance imaging (MRI) of the trachea revealed a 2-cm region of severe subglottic tracheal stenosis with marked increase in tracheal wall thickness (Figure 1). High resolution computed tomography scan (HRCT) of the thorax did not show any abnormalities.
Table 1

Sequential evaluation of pulmonary function tests.

Parameter

September 2004

October 2004

December 2004

February 2005

July 2005

FVC

3.47 (102)

3.59 (106)

3.56 (106)

3.71 (107.5)

3.88 (112.3)

FEV1

1.28 (43.5)

1.6 (54.3)

2.76 (94.5)

3.19 (106.5)

3.39 (113)

FEV1/FVC%

36.9

44.5

77.6

86.05

87.42

FEF25–75 L/s

1.13 (29.2)

1.41 (36.4)

2.72 (71.1)

3.51 (91.1)

4.00 (103.7)

Data in parentheses are percentage of predicted value. Measurements in September 2004 were taken on admission; those in October 2004 and December 2004 were after 4 weeks and 12 weeks of oral and inhaled steroids, respectively; those in February 2005 were after 20 weeks of therapy; and those in July 2005 after bronchoscopic dilatation and 40 weeks of therapy. FVC: forced vital capacity; FEV1: forced expiratory volume in one second; FEF25–75: forced mid-expiratory flow.

Figure 1

Magnetic Resonance Imaging (MRI). MRI_axial: (A) Axial T1-weighted Spin Echo (SE) MRI shows circumferential thickening of the trachea (white arrow) with intermediate signal intensity of the thickened mucosa/submucosa. (B) T2-weighted Turbo SE MRI at the same level. Note the pathological high signal intensity of the thickened mucosa/submucosa, which corresponds to mucosal inflammation. MRI_sag: (C) Sagittal T1-weighted SE MRI shows irregular narrowing of the airway (white arrow). (D) Sagittal T2-weighted Turbo SE MRI of the subglottic trachea shows thickening of the tracheal lumen with high signal intensity due to inflammation.

A fiberoptic bronchoscopy (FOB) was performed, and showed severe circumferential tracheal stenosis, greater than 70%, 1–2 cm beneath the vocal cords and marked inflammation of tracheal mucosa (Figure 2A). The patient did not tolerate penetration of the bronchoscope through the obstruction. Bacteriologic studies of bronchial washings, including cultures for mycobacteria and fungi, were negative. Cytologic studies of bronchial washings showed inflammatory cells and no malignant cells. Histological examination of several biopsies of the stenosed areas revealed acute and chronic inflammation and extended ulceration of bronchial mucosa, without granulomas (Figure 2B).
Figure 2

Fiberoptic bronchoscopy and histological examination of tracheal stenosis. (A) Circumferential tracheal stenosis, greater than 70%, 1–2 cm beneath the vocal cords and marked inflammation of tracheal mucosa was noted at fiberoptic bronchoscopy. (B) Histological examination revealed acute and chronic inflammation and extended ulceration of bronchial mucosa, without granulomas.

The patient received inhaled budesonide 800 μg·day-1 and methylprednisolone 120 mg·day-1 iv for 5 days. Then she continued on oral methylprednisolone 24 mg·day-1 and inhaled budesonide 800 μg·day-1. During the following months she reported improvement of her shortness of breath, accompanied by gradual improvement of her lung function tests (Table 1). In May 2005 she was referred to the Complex Airway Center of the Beth Israel Deaconess Medical Center for further evaluation.

On presentation in the Complex Airway Center, her throat on auscultation revealed mild inspiratory stridor. There was otherwise no wheezing, chest exam was normal, as was the remainder of her examination, and room air oxygenation was 99%. A specialized airway CT was performed, which demonstrated a 2-cm region of circumferential subglottic stenosis with focal narrowing that did not spare the membranous portion of the trachea (Figure 3). The remainder of the trachea appeared unremarkable without evidence of tracheobronchomalacia. There were regions of patchy ground glass opacity in the superior segment of the right middle lobe, with some centrilobular nodular opacities and patchy opacities in the right lower lobe superior segment with air trapping.
Figure 3

Computed Tomography (CT). (A) CT_ volume rendering technique (VRT): The VRT of the tracheobronchial tree, clearly demonstrates the segment of irregular stenosis of the subglottic trachea (white arrow). (B) CT _axial: CT scan shows marked circumferential narrowing of the subglottic part of the trachea. No calcification can be seen. (C and D) CT_sag_multi planar reconstruction (MPR): On (C) end-expiration and (D) end-inspiration sagittal MPR of CT scan, a dynamic collapse of the trachea can not be documented.

At flexible bronchoscopy a high-grade subglottic obstruction was visible at about 7 or 8 mm diameter opening. The obstruction was complex, reaching from the posterior subglottic area close to the vocal cords and posterior arytenoids all the way down to the cricoid ring in a circular fashion. Rigid bronchoscopy confirmed the subglottic stenosis and showed that it extended into the first tracheal ring. The area was biopsied, dilated sequentially to 12 mm and the remaining tissues were cleanly ablated with the help of a microdebrider. The diameter achieved in the end was approximately 14 mm and appeared normal for her size. Five cc of 0.04% mitomycin-C was also applied for four minutes. During the rigid bronchoscopy several additional abnormalities were visualized. The left upper lobe was near-totally occluded by a web-like obstruction, which was also biopsied and dilated. Moreover, the right medial segment of the right lower lobe was near-totally occluded with what appeared to be mucosal and submucosal swelling, which was again extensively biopsied and a lumen was reestablished. The pathology results revealed partially ulcerated respiratory mucosa with squamous metaplasia, lamina propria fibrosis, recent hemorrhages and acute and chronic inflammation in all three locations, but no granulomas.

This treatment led to complete remission of the patient's respiratory symptoms up to the point that this report is written, 10 months after dilatation. She continued treatment with oral methylprednisolone 24 mg·day-1, inhaled budesonide 800 μg·day-1 and oral omeprazole 20 mg·day-1. The patient will be closely followed with pulmonary function tests and endoscopic approaches, if necessary, and progressive tapering of oral steroid treatment over the following months will be attempted.

Conclusion

The authors report a case of a young female with CD, who developed tracheal inflammation and stenosis that improved but persisted, despite corticosteroid treatment. Although the lungs are not a common site of involvement, pulmonary lesions have been reported in CD. Latent pulmonary involvement might be more frequent than considered and subclicinal abnormalities, like increased bronchial hyperresponsiveness [11, 12], impairement of lung function parameters [13, 14], increased lymphocyte numbers in bronchoalveolar lavage and induced sputum [15, 16] and increase of lung permeability [17], have been well-described.

In the present case, other disease processes that might cause a similar picture had to be excluded. Tuberculous stenosis is an endobronchial complication of pulmonary tuberculosis. In this patient, mycobacterial infection could be excluded by the absence of caseating granulomas, negative tuberculin skin test, and failure to identify mycobacteria on culture. Sarcoidosis and CD share pathologic and immunologic features [18]. In this case, there was little evidence in favor of sarcoidosis: there was no extrapulmonary sarcoid involvement, no mediastinal lymph node involvement, sACE level was normal and typical sarcoid granulomata in bronchial biopsies were absent. Moreover, the absence of histological findings suggestive of Wegener's granulomatosis, the lack of cytoplasmic-ANCA and no extrapulmonary involvement, made the diagnosis of Wegener's granulomatosis unlikely. Relapsing polychondritis was excluded on the basis of clinical, radiological and histological criteria.

Tracheobronchial involvement is rare in CD, but has been reported before [19, 19]. Mucosal inflammation of the trachea and bronchi may be observed, with or without upper airway stenosis, in any age group. Histologically, there may be airway infiltration by inflammatory cells and mucosal ulceration, but non-caseating granulomas are not always present [1, 8]. The diagnosis of CD usually precedes the presentation of pulmonary manifestations, but previously undiagnosed CD presenting with airway manifestations has also been reported [4]. Symptoms of tracheobronchial involvement usually respond well to appropriate doses of inhaled and/or systemic steroids. In the present case, however, although the patient reported improvement with steroid treatment, she still complained of symptoms compromising her quality of life, making a more invasive approach necessary. Bronchoscopic dilatation led to complete remission of her symptoms. Stent placement was not feasible as the lesion was in the glottic and subglottic space involving the vocal cords. The lesions were not approachable surgically as they were multifocal and still revealed chronic inflammation. Surgery could be indicated at a later point when the inflammation has turned into fibrosis. Aggressive treatment with inhaled and oral steroids is still necessary for this patient to avoid relapse, since inflammation is an ongoing process.

In summary, this is a report of a patient with CD who developed severe airway obstruction, despite the fact that gastrointestinal symptoms were well-controlled on conventional CD treatment. Systemic and inhaled steroid treatment led to some improvement, in agreement with previous reports of the effectiveness of steroid administration in similar cases [1]. In this case however, mucosal inflammation and symptoms persisted, making a more invasive approach necessary. Interventional pulmonary medicine has made great progress during recent years, proving to be a valuable tool for respiratory physicians. To our knowledge this is the first report of a patient with tracheal stenosis from CD successfully treated with rigid bronchoscopy and dilatation. Respiratory involvement in CD might be more common than appreciated and the need exists for early diagnosis and appropriate treatment of airway complications, which might otherwise prove to be life-threatening.

Notes

Abbreviations

(ANCA): 

anti-neutrophil cytoplasmic antibodies

(CD): 

Crohn's disease

(FOB): 

fiberoptic bronchoscopy

(FEV1): 

forced expiratory volume in one second

(HRCT): 

high resolution computed tomography scan

(MRI): 

magnetic resonance imaging

(sACE): 

serum angiotensin-converting enzyme

Declarations

Acknowledgements

Written consent was obtained from the patient for publication of study.

Authors’ Affiliations

(1)
Department of Thoracic Medicine, University Hospital of Heraklion
(2)
Department of Pathology, University Hospital of Heraklion
(3)
Department of Medicine, Beth Israel Deaconess Medical Center

References

  1. Camus PH, Piard F, Ashcroft TH, Gal AA, Colby TV: The lung in inflammatory bowel disease. Medicine. 1993, 72: 151-183.View ArticlePubMedGoogle Scholar
  2. Kraft SC, Earle RH, Roesler M, Esterly JR: Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med. 1976, 136: 454-459. 10.1001/archinte.136.4.454.View ArticlePubMedGoogle Scholar
  3. Kuzniar T, Sleiman C, Brugiere O, Groussard O, Mal H, Mellot F, Pariente R, Malolepszy J, Fournier M: Severe tracheobronchial stenosis in a patient with Crohn's disease. Eur Respir J. 2000, 15: 209-212. 10.1183/09031936.00.15120900.PubMedGoogle Scholar
  4. Ahmed KA, Thompson JW, Joyner RE, Stocks RM: Airway obstruction secondary to tracheobronchial involvement of asymptomatic undiagnosed Crohn's disease in a pediatric patient. Int J Pediatr Otorhinolaryngol. 2005, 69: 1003-1005.View ArticlePubMedGoogle Scholar
  5. Henry MT, Davidson LA, Cooke NJ: Tracheobronchial involvement with Crohn's disease. Eur J Gasstroenterol Hepatol. 2001, 13: 1495-1497. 10.1097/00042737-200112000-00015.View ArticleGoogle Scholar
  6. Kelly JH, Montgomery WW, Goodman ML, Mulvaney TJ: Upper airway obstruction associated with regional enteritis. Ann Otol Rhinol Laryngol. 1979, 88: 95-99.View ArticlePubMedGoogle Scholar
  7. Ulrich R, Goldberg R, Line WS: Crohn's disease: a rare cause of upper airway obstruction. J Emerg Med. 2000, 19: 331-332. 10.1016/S0736-4679(00)00258-4.View ArticlePubMedGoogle Scholar
  8. Lemann M, Messing B, D'Agay F, Modigliani R: Crohn's disease with respiratory tract involvement. Gut. 1987, 28: 1669-1672.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Iwama T, Higuchi T, Imajo M, Akagawa S, Matsubara O, Mishima Y: Tracheo-bronchitis as a complication of Crohn's disease – a case report. Jpn J Surg. 1991, 21: 454-457.View ArticlePubMedGoogle Scholar
  10. Hotermans G, Benard A, Guenanen H, Demarcq-Delerue G, Malart T, Wallaert B: Nongranulomatous interstitial lung disease in Crohn's disease. Eur Respir J. 1996, 9: 380-382. 10.1183/09031936.96.09020380.View ArticlePubMedGoogle Scholar
  11. Louis E, Louis R, Shute J, Lau L, Franchimont D, Lamproye A, Radermecker M, Djukanovic R, Belaiche J: Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy. 1999, 29: 660-666. 10.1046/j.1365-2222.1999.00508.x.View ArticlePubMedGoogle Scholar
  12. Louis E, Louis R, Drion V, Bonnet V, Lamproye A, Radermecker M, Belaiche J: Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy. 1995, 50: 729-733.View ArticlePubMedGoogle Scholar
  13. Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K: Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol. 2002, 97: 377-381. 10.1111/j.1572-0241.2002.05473.x.View ArticlePubMedGoogle Scholar
  14. Tzanakis N, Samiou M, Bouros D, Mouzas J, Kouroumalis E, Siafakas NM: Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med. 1998, 157: 382-386.View ArticlePubMedGoogle Scholar
  15. Wallaert B, Colombel JF, Tonnel AB, Bonniere P, Cortot A, Paris JC, Voisin C: Evidence of lymphocyte alveolitis in Crohn's diease. Chest. 1985, 87: 363-367.View ArticlePubMedGoogle Scholar
  16. Fireman Z, Osipov A, Kivity S, Kopelman Y, Stemberg A, Lazarov E, Fireman E: The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease. Am J Gastroenterol. 2000, 95: 730-734. 10.1111/j.1572-0241.2000.01843.x.View ArticlePubMedGoogle Scholar
  17. Wallaert B, Adenis A, Lecouffe P, Collet R, Colombel JF, Machandise X: Increased pulmonary epithelial permeability in Crohn's disease. Am Rev Respir Dis. 1990, 141: A319-View ArticleGoogle Scholar
  18. McCormick PA, O'Donoghue DP, Fitzgerald MX: Crohn's colitis and sarcoidosis. Postgrad Med. 1986, 62: 951-953.View ArticleGoogle Scholar
  19. Lamblin C, Copin MC, Billaut C, Marti R, Tacq V, Riviere O, Wallaert B: Acute respiratory failure due to tracheobronchial involvement in Crohn's disease. Eur Respir J. 1996, 9: 2176-2178. 10.1183/09031936.96.09102176.View ArticlePubMedGoogle Scholar
  20. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2466/6/7/prepub

Copyright

© Plataki et al; licensee BioMed Central Ltd. 2006

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement